<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04676269</url>
  </required_header>
  <id_info>
    <org_study_id>19-10-1202</org_study_id>
    <nct_id>NCT04676269</nct_id>
  </id_info>
  <brief_title>Amnion Bilayer and Stem Cell Combination Therapy on Thin Endometrium Infertile Patients</brief_title>
  <official_title>Amnion Bilayer and Stem Cell Combination Therapy on Thin Endometrium Infertile Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indonesia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indonesia University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Severe infections or trauma to the endometrial lining causes permanent scars that disrupt the&#xD;
      menstrual cycle and lead to conceive failure. Transplantation of biological graft seeded with&#xD;
      stem cells is purposed to regenerate and recover the capability of the endometrial lining&#xD;
      back into its cycles. Initially, the techniques to isolate and culture the endometrial cells&#xD;
      and amnion epithelial stem cells were developed, then the endometrial cells form patients&#xD;
      with thin endometrium. Tissue were obtained from hysteroscopic biopsy, weight between 100 µl,&#xD;
      while up to 20 µl from the thin endometrium. Tissue were digested using collagenase-1 and&#xD;
      cultured using DMEM-F12 added wit epidermal growth factor. Endometrial cells will be&#xD;
      characterized to SSUD2, ICAM and BRCP1. Amnion epithelial stem cells (hAESC) will be isolated&#xD;
      using collagenase-1 and hyaluronidase. Characterization towards TRA-1-60, SSEA-4, Oct 3/4,&#xD;
      and Nanog. In the future, the cells will be co-culture on amnion bilayer, and stained using&#xD;
      IHC against α-cadherin, estrogen receptor α, progesterone receptor. Endometrial receptivity&#xD;
      (HOXA10, LIF (early secretory) adhesion, VEGF, osteopontin (SPP1) to indicate the pinopodes&#xD;
      will be identified using qPCR.The SPP1, target of MIR424 expressed during the receptive&#xD;
      phase.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 9, 2019</start_date>
  <completion_date type="Anticipated">December 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 15, 2021</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>None of the participants, gynecologists, statistician, nurses nor of the participant' partners are informed about the treatment groups.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in endometrium thickness</measure>
    <time_frame>7 and 14 days after amnion bilayer seeded with endometrial cells co-cultured with hAESC is transplanted into patient' womb</time_frame>
    <description>Observation by USG</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in amenorrhea severity</measure>
    <time_frame>7 and 14 days after amnion bilayer seeded with endometrial cells co-cultured with hAESC is transplanted into patient' womb</time_frame>
    <description>Patients' report</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Cell- and Tissue-Based Therapy</condition>
  <arm_group>
    <arm_group_label>Amnion only</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Amnion bilayer as a scaffold to overlay the endometrium, with minor curettage prior to stick the scaffold.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Amnion- self endometrium stem cells (EnSC)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Amnion bilayer as a scaffold, seeded with endometrium stem cells to regenerate the thin endometrium.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Amnion- amnion epithelial stem cells (AESC)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Amnion bilayer as a scaffold, seeded with amnion epithelial stem cells to regenerate the thin endometrium.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Amnion- co culture self EnSC - AESC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Amnion bilayer as a scaffold, seeded with co-culture of endometrium stem cells and amnion epithelial stem cells to regenerate the thin endometrium.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Amnion only</intervention_name>
    <description>Patients endometrium will be transplanted with amnion only (without seeded cells)</description>
    <arm_group_label>Amnion only</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Amnion - endometrium cells</intervention_name>
    <description>Patients endometrium will be transplanted with amnion seeded with endometrium cells isolated from the patients themselves</description>
    <arm_group_label>Amnion- self endometrium stem cells (EnSC)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Amnion - amnion epithelial cells</intervention_name>
    <description>Patients endometrium will be transplanted with amnion seeded with amnion epithelial stem cells isolated from other patients' caesarean sectio amnion membrane (tested HLA-DR negative to prevent rejection)</description>
    <arm_group_label>Amnion- amnion epithelial stem cells (AESC)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Amnion-EnSC-AESC</intervention_name>
    <description>Patients endometrium will be transplanted with amnion seeded with endometrium cells-amnion epithelial stem cells co-culture</description>
    <arm_group_label>Amnion- co culture self EnSC - AESC</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with thin endometrium without scar&#xD;
&#xD;
          -  Patients with acute thin endometrium post-therapy (medicamentosa)&#xD;
&#xD;
          -  Patients who are willing to participate in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with thin endometrium due to TB&#xD;
&#xD;
          -  Patients with cancer in the reproductive system&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Achmad Kemal Harzif, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Medicine, Indonesia University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Achmad Kemal Harzif, MD</last_name>
    <phone>+62 813-1586-6390</phone>
    <email>kemal.achmad@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Normalina Sandora, PhD</last_name>
    <phone>+62 812-9896-3425</phone>
    <email>normalinasandora@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>RSUPN Cipto Mangunkusumo</name>
      <address>
        <city>Jakarta Pusat</city>
        <state>DKI Jakarta</state>
        <zip>10430</zip>
        <country>Indonesia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Achmad Kemal Harzif, MD</last_name>
      <phone>+6281315866390</phone>
      <email>kemal.achmad@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Normalina Sandora, PhD</last_name>
      <phone>+6281298963425</phone>
      <email>normalina.sandora@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 2, 2020</study_first_submitted>
  <study_first_submitted_qc>December 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 21, 2020</study_first_posted>
  <last_update_submitted>December 15, 2020</last_update_submitted>
  <last_update_submitted_qc>December 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indonesia University</investigator_affiliation>
    <investigator_full_name>dr. Achmad Kemal Harzif, SpOG (K)</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Endometrial stem cells</keyword>
  <keyword>Amnion epithelial stem cells</keyword>
  <keyword>Amnion bilayer</keyword>
  <keyword>Thin endometrium</keyword>
  <keyword>Secondary amenorrhoe</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

